New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases

Age-related cardiovascular disease is the leading cause of death in elderly populations. Coxibs, including celecoxib, valdecoxib, etoricoxib, parecoxib, lumiracoxib, and rofecoxib, are selective cyclooxygenase-2 (COX-2) inhibitors used to treat osteoarthritis and rheumatoid arthritis. However, many...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wujun, Zhong, Yingjie, Feng, Nuan, Guo, Zhu, Wang, Shuai, Xing, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482621/
https://www.ncbi.nlm.nih.gov/pubmed/34592918
http://dx.doi.org/10.1186/s10020-021-00358-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482621/
https://www.ncbi.nlm.nih.gov/pubmed/34592918
http://dx.doi.org/10.1186/s10020-021-00358-4

Ejemplares similares